AVENTIS INC 4
4 · INTROGEN THERAPEUTICS INC · Filed Sep 12, 2003
Insider Transaction Report
Form 4
AVENTIS INC
Other
Transactions
- Sale
Common
2003-09-11$8.77/sh−300,000$2,631,000→ 3,560,293 total(indirect: (1)) - Sale
Common
2003-09-10$8.46/sh−108,600$918,756→ 3,860,293 total(indirect: (1))
Footnotes (1)
- [F1](1) Owned directly by Aventis Holdings Inc. and beneficially owned by Aventis Inc.